MORGAN STANLEY - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 32 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$175
-30.0%
2190.0%0.00%
Q2 2023$250
-99.9%
219
-99.8%
0.00%
Q1 2023$192,967
+51912.7%
128,644
+51564.3%
0.00%
Q4 2022$371
-98.2%
249
-98.2%
0.00%
Q3 2022$21,000
-64.4%
13,569
-48.2%
0.00%
Q2 2022$59,000
+136.0%
26,175
+136.1%
0.00%
Q1 2022$25,000
-88.3%
11,086
-69.9%
0.00%
Q4 2021$214,000
+511.4%
36,846
+1011.5%
0.00%
Q3 2021$35,000
-96.7%
3,315
-96.9%
0.00%
Q2 2021$1,051,000
+994.8%
107,726
+1538.4%
0.00%
Q1 2021$96,0006,5750.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Alpha Wave Global, LP 213,658$3,104,0000.19%
Serengeti Asset Management LP 20,000$291,0000.13%
FORMULA GROWTH LTD 56,276$818,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 375,000$5,449,0000.12%
TUDOR INVESTMENT CORP ET AL 113,353$1,647,0000.03%
Duquesne Family Office 100,000$1,453,0000.03%
PURA VIDA INVESTMENTS, LLC 67,357$941,0000.03%
MOORE CAPITAL MANAGEMENT, LP 127,500$1,853,0000.02%
Zimmer Partners, LP 46,000$668,0000.01%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 26,000$376,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders